The holidays are coming, and that means it’s travel time for many to spend time with friends and family. If you have diabetes, you should be
Eli Lilly and Company reported that it’s drug, Trulicity® significantly reduced major adverse cardiovascular events, a composite endpoint of
Out-of-control insulin costs have created a dangerous barrier for many people with diabetes who need to access lifesaving treatments. According to
Xeris Pharmaceuticals, Inc. announced today that its new drug application (NDA) for its ready-to-use, room-temperature stable liquid glucagon rescue
Genentech announced yesterday that the U.S. Food and Drug Administration (FDA) has approved XOFLUZA™ for the treatment of the flu, in patients
Minnesota Attorney General Lori Swanson is the latest to file a lawsuit against the nation’s three largest insulin makers, Sanofi-Aventis U.S.
Tresiba®, an insulin degludec injection, has received an expanded approval for the treatment of Type 1 diabetes in pediatric patients in Canada.
Using lipid-lowering medication with fibrates, including fenofibrate and statins reduces not only the incidence of diabetic retinopathy in patients
The American Diabetes Association (ADA) is urging people to sign a petition to support those struggling with insulin affordability. More than
The U.S. Food and Drug Administration is warning patients and doctors about a rare but serious infection that has been reported with a common class
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: